Small For Gestational Age
📧 Sign up to get email alerts when something new happens for Small For Gestational Age.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-08-16FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer, resulting in changes to the labeling. The notice reflects t…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: The Effectiveness of Audiovisual Intervention [NA]
Clinical trial update on the effectiveness of an audiovisual intervention for premature infants and parent-child relations; the study is not…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Clinical trial update describing a study that monitors bioimpedance and arterial function at birth and in infancy; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day [Phase 2]
Phase 2 study comparing weekly somapacitan to daily Norditropin in children born small for gestational age; results were posted in 2024.
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina Faso
Ongoing ClinicalTrials.gov study in Burkina Faso comparing biological vulnerability in small vulnerable newborns vs healthy controls, focusi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) [Phase 4]
Phase 4 trial update on safety and efficacy of Omnitrope (rhGH) in children born small for gestational age (SGA).
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: A Trial of YPEG-rhGH in Children With Short Stature [Phase 2]
Phase 2 trial update for YPEG-rhGH in children with short stature, including idiopathic short stature and small for gestational age conditio…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants [NA]
Study evaluating personalized nutrition strategies for very low birth weight preterm infants has completed, with results posted in May 2021.
-
FDA approval · 2020-03-09FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) by Novo Nordisk under BLA021148. The action pertains to changes approve…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"
Clinical trial update for Genotropin long follow-up in patients with small for gestational age (SGA) completed; results posted in 2020.
-
FDA approval · 2020-01-08FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Genotropin (somatropin) via a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2018-11-09Clinical Trial Update: Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. [Phase 2]
A Phase 2 trial evaluating whether low-dose aspirin affects birthweight in twins, with outcomes including small for gestational age and very…
-
CLINICAL_TRIALS research · 2018-04-19Clinical Trial Update: Probiotics and Early Microbial Contact in Preterm Neonates [NA]
Clinical trial update on probiotics and early microbial contact in preterm neonates; the current status is unknown.
-
FDA approval · 2018-01-30FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) by Ferring Pharmaceuticals. The action updates the product's indications o…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA [Phase 2]
Phase 2 trial evaluating recombinant human growth hormone (JINTOPIN AQ) for short children with Small for Gestational Age; study status comp…
-
CLINICAL_TRIALS research · 2017-12-12Clinical Trial Update: A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA) [Phase 3]
Phase 3 trial evaluating recombinant human growth hormone injections for short children with small-for-gestational-age; current status is un…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health [NA]
The NACER II trial in rural Guatemala tested a gas stove/behavior intervention to reduce prenatal exposure to household air pollution and im…
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Observational Prospective Study on Patients Treated With Norditropin®
An observational prospective study assesses outcomes in patients treated with Norditropin (somatropin) for growth hormone-related disorders.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Breast Milk Zinc Transfer to Appropriate- and Small-for-gestational-age Bangladeshi Infants
This completed clinical trial from ICDDR,B evaluated breast milk zinc transfer to Bangladeshi infants who are appropriate-for-gestational-ag…
-
FDA label_change · 2017-05-24FDA Approved: SEROSTIM — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for SEROSTIM (somatropin) from EMD Serono, Inc. to update the product labeling. The changes expand o…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age [Phase 3]
A Phase 3 trial evaluating growth hormone treatment in children who are small for gestational age reports efficacy and safety results; the s…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation [Phase 4]
Phase 4 study update on the long-term effects of somatropin in subjects with intrauterine growth retardation.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World
This entry reports the completion of a Duke University-sponsored trial evaluating novel screening tools for the evaluation and management of…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects
Long-term metabolic safety data from a study of Norditropin in children with Small for Gestational Age have been completed and updated.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years [Phase 3]
Two-sentence summary: A Phase 3 trial evaluating growth hormone treatment in children born with intrauterine growth restriction (retarded in…